Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: review decision - June 2015 information

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - RPP decision paper - June 2015

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - RPP decision paper - June 2015 (PDF 66 KB)

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: review decision - May 2015 information

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - matrix of stakeholders

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - matrix of stakeholders (PDF 100 KB)

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix B - GE proposal paper April 2015

Pulmonary embolism (acute treatment, VTE prevention): rivaroxaban equality impact assessment - guidance review

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination information

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document (PDF 268 KB)

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: evaluation report information

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix B - Final scope

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix C - Final matrix

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix D - scope consultation comments table

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: equality impact assessment form

Pulmonary embolism (acute treatment, VTE prevention - rivaroxaban: appendix A draft scope for consultation (post referral) October 2012

Pulmonary embolism (acute treatment, VTE prevention - rivaroxaban: appendix B draft matrix for consultation (post referral) October 2012

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix B - draft scope for consultation (pre-referral) August 2010 

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix C - provisional matrix (pre-referral) August 2010